Results 171 to 180 of about 72,548 (342)

Results of neoadjuvant denosumab in giant cell tumor of the bone depending of the tumor location and the surgical grade

open access: hybrid, 2021
A. A. Tararykova   +8 more
openalex   +2 more sources

ALK‐Positive Histiocytosis With Unilateral Breast Involvement: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT APH is a rare disorder characterized by the proliferation of ALK‐expressing histiocytes with variable anatomical involvement; however, mammary involvement is exceptionally rare. A 32‐year‐old woman presented with a painless right breast mass. Ultrasound identified a 9 × 8 mm hypoechoic nodule, categorized as BI‐RADS 4A.
Xuechun Liu, Dong Ren, Yanfang Liang
wiley   +1 more source

Ring Finger Mass: A Rare Case of Digital Actinomycosis Surgically Removed From a Young Patient

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Actinomycosis is an uncommon chronic granulomatous infection that typically resides as commensals in the oral cavity, gastrointestinal tract, and female genital tract. Involvement of the extremities, particularly the digits and underlying bone, is extremely rare, especially in young age, often leading to diagnostic delays and therapeutic ...
Abdulkarim Hasan   +9 more
wiley   +1 more source

Renal Angiomyolipoma in a Young Woman With Tuberous Sclerosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Tuberous sclerosis is a rare autosomal dominant genetic disorder caused by mutations in tumor suppressor genes (TSC1/2), leading to hamartomas in multiple organs. Renal angiomyolipomas are often asymptomatic but can cause mass effects or bleeding if they enlarge, requiring treatment.
Donald Dominick Lema   +7 more
wiley   +1 more source

Practical implications of the World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Categories and ancillary testing for subtyping of hematolymphoid tumors on FNA biopsy cytopathology using a pattern‐based approach

open access: yesCancer Cytopathology, Volume 134, Issue 1, January 2026.
Abstract The objective of the recently published World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology (WHO system) is to standardize the diagnostic approach to fine‐needle aspiration biopsies of hematolymphoid tissues.
Mats Ehinger   +4 more
wiley   +1 more source

Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-β1 and -β2 expression may explain metaplastic bone formation

open access: hybrid, 1996
Lisa A. Teot   +5 more
openalex   +1 more source

Single‐nucleus RNA sequencing reveals the distinct heterogeneity of primary pulmonary sarcomas (PPS) and pulmonary sarcomatoid carcinoma (PSC)

open access: yesClinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Single‐nucleus RNA sequencing (snRNA‐seq) maps the cellular diversity of pulmonary sarcomatoid carcinoma (PSC) and primary pulmonary sarcomas (PPS). AT2 cells, a major source of epithelial cells in PSC, underwent malignant transformation primarily through epithelial–mesenchymal transition, suggesting AT2 cells may serve as the origin of PSC.
Jianfei Zhu   +11 more
wiley   +1 more source

Artificial Intelligence‐Based In Silico Evaluation of the Pharmacological Potential and In Vitro Anti‐Malignancy Effect in the Human Glioblastoma Cell Line of the Hydrate of the Coumarin Compound Meranzin Originating From the Edible Macroalga (Bangia fuscopurpurea)

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
In U87 cells, meranzin hydrate showed cytotoxicity (MIC = 50 μM) and anti‐invasion activity (IC50 = 33.12 μM) but had no inhibitory effect on colony formation. It also suppressed the cancer stem cell property of sphere formation (IC50 = 21.43 μM). In silico analysis indicated that meranzin hydrate may downregulate the protein expression of ALDH1A1 and ...
Shi‐Ying Huang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy